Pruteanu-Malinici, Iulian
3 papers on CoChatORCID 0000-0002-9787-2985
Most cited papers
- Verified
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine
CAR-T cell therapy researchChronic Lymphocytic Leukemia Research
Cited by 1,785
- Verified
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Cohen, A. D., Garfall, A. L., Stadtmauer, E. A., Melenhorst, J. J., Lacey, S. F., Lancaster, E., Vogl, D. T., Weiss, B. M., Dengel, K., Nelson, A., et al. (2019) · Journal of Clinical Investigation
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 778
- Verified
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
Grauel, A. L., Nguyen, B., Ruddy, D., Laszewski, T., Schwartz, S., Chang, J., Chen, J., Piquet, M., Pelletier, M., Yan, Z., et al. (2020) · Nature Communications
TGF-β signaling in diseasesCancer Cells and Metastasis
Cited by 211
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free